| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6120450 | Journal of Clinical Virology | 2015 | 5 Pages |
Abstract
First-line NNRTI-based treatment can produce virological success in naïve HIV-1-infected patients harboring low-frequency DRMs representing <1% of the viral quasispecies. Further studies are needed to determine the clinical cut-off of low-frequency resistant variants associated to virological failure.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
F. Nicot, K. Sauné, S. Raymond, N. Jeanne, R. Carcenac, C. Lefebvre, L. Cuzin, B. Marchou, P. Delobel, J. Izopet,